Pharmacokinetics and pharmacodynamics of ticagrelor in subjects on hemodialysis and subjects with normal renal function

Por Teng, Renli, Muldowney, Sharen, Zhao, Yonggang, Berg, Jolene Kay, Lu, Jonathan, Khan, Naeem D.
Publicado no Eur J Clin Pharmacol (2018)

Difference in Medication Adherence Between Patients Prescribed a 30‐Day Versus 90‐Day Supply After Acute Myocardial Infarction

Por Rymer, Jennifer A., Fonseca, Eileen, Bhandary, Durgesh D., Kumar, Deepa, Khan, Naeem D., Wang, Tracy Y.
Publicado no J Am Heart Assoc (2020)

Clinically feasible stratification of 1-year to 3-year post-myocardial infarction risk

Por Horne, Benjamin D, Muhlestein, Joseph B, Bhandary, Durgesh, Hoetzer, Greta L, Khan, Naeem D, Bair, Tami L, Lappé, Donald L
Publicado no Open Heart (2018)

Impact of Diabetes Mellitus on the Pharmacodynamic Effects of Ticagrelor Versus Clopidogrel in Troponin‐Negative Acute Coronary Syndrome Patients Undergoing Ad Hoc Percutaneous Cor...

Por Sweeny, Joseph M., Angiolillo, Dominick J., Franchi, Francesco, Rollini, Fabiana, Waksman, Ron, Raveendran, Ganesh, Dangas, George, Khan, Naeem D., Carlson, Glenn F., Zhao, Yonggang, Teng, Renli, Mehran, Roxana
Publicado no J Am Heart Assoc (2017)

Addressing Therapeutic Inertia in 2020 and Beyond: A 3-Year Initiative of the American Diabetes Association

Por Gabbay, Robert A., Kendall, Debbie, Beebe, Christine, Cuddeback, John, Hobbs, Todd, Khan, Naeem D., Leal, Sandra, Miller, Eden, Novak, Lucia M., Rajpathak, Swapnil N., Scribner, Paul, Meneghini, Luigi, Khunti, Kamlesh
Publicado no Clin Diabetes (2020)

Effect of Medication Co-payment Vouchers on P2Y(12) Inhibitor Use and Major Adverse Cardiovascular Events Among Patients With Myocardial Infarction: The ARTEMIS Randomized Clinical...

Por Wang, Tracy Y., Kaltenbach, Lisa A., Cannon, Christopher P., Fonarow, Gregg C., Choudhry, Niteesh K., Henry, Timothy D., Cohen, David J., Bhandary, Durgesh, Khan, Naeem D., Anstrom, Kevin J., Peterson, Eric D.
Publicado no JAMA (2019)

Association of a P2Y(12) Inhibitor Copayment Reduction Intervention With Persistence and Adherence With Other Secondary Prevention Medications: A Post Hoc Analysis of the ARTEMIS C...

Por Fanaroff, Alexander C., Peterson, Eric D., Kaltenbach, Lisa A., Cannon, Christopher P., Choudhry, Niteesh K., Henry, Timothy D., Anstrom, Kevin J., Cohen, David J., Fonseca, Eileen, Khan, Naeem D., Fonarow, Gregg C., Wang, Tracy Y.
Publicado no JAMA Cardiol (2019)

Agreement and Accuracy of Medication Persistence Identified by Patient Self-report vs Pharmacy Fill: A Secondary Analysis of the Cluster Randomized ARTEMIS Trial

Por Fanaroff, Alexander C., Peterson, Eric D., Kaltenbach, Lisa A., Cannon, Christopher P., Choudhry, Niteesh K., Henry, Timothy D., Anstrom, Kevin J., Cohen, David J., Fonseca, Eileen, Khan, Naeem D., Fonarow, Gregg C., Wang, Tracy Y.
Publicado no JAMA Cardiol (2020)

Oral Antiplatelet Therapy Administered Upstream to Patients With NSTEMI

Por Pollack, Charles V., Peacock, W. Frank, Bhandary, Durgesh D., Silber, Steven H., Bhalla, Narinder, Rao, Sunil V., Diercks, Deborah B., Frost, Alex, Bangalore, Sripal, Heitner, John F., Johnson, Charles, DeRita, Renato, Khan, Naeem D.
Publicado no Crit Pathw Cardiol (2020)